Perrigo Company plc Loans Payable
Perrigo Company plc (PRGO) had Loans Payable of $1.41 billion as of 2025-06-28, per its 10-Q filed 2025-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:LoansPayable · last filed 2025-08-06
- 2025-06-28: Loans Payable $1.41B.
- 2025-03-29: Loans Payable $1.42B.
- 2024-12-31: Loans Payable $1.43B.
- 2024-09-28: Loans Payable $1.44B.
| Period end | Loans Payable | Loans Payable as first filed |
|---|---|---|
| 2025-06-28 | $1.41B 10-Q · filed 2025-08-06 | |
| 2025-03-29 | $1.42B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.43B 10-Q · filed 2025-08-06 | |
| 2024-09-28 | $1.44B 10-Q · filed 2024-11-06 | |
| 2024-06-29 | $1.84B 10-Q · filed 2024-08-02 | |
| 2024-03-30 | $1.85B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.86B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $1.56B 10-Q · filed 2023-11-07 | |
| 2023-07-01 | $1.57B 10-Q · filed 2023-08-08 | |
| 2023-04-01 | $1.58B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.59B 10-K · filed 2024-02-27 | |
| 2022-10-01 | $1.59B 10-Q · filed 2022-11-08 | |
| 2022-07-02 | $1.60B 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $600.00M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $600.00M 10-K · filed 2020-02-27 | |
| 2018-12-31 | $351.30M 10-K · filed 2020-02-27 | |
| 2018-09-29 | $368.30M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $383.50M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $417.90M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $420.00M 10-K · filed 2019-02-27 | |
| 2015-12-31 | $488.80M 10-KT · filed 2016-02-25 | |
| 2015-09-26 | $300.00M 10-Q · filed 2016-11-10 | |
| 2015-06-27 | $300.00M 10-K · filed 2018-03-01 | $530.50M 10-K · filed 2015-08-13 |
| 2015-03-28 | $830.90M 10-Q · filed 2015-04-29 | |
| 2014-12-27 | $908.90M 10-Q · filed 2015-02-05 | |
| 2014-12-05 | $300.00M 10-Q/A · filed 2017-05-23 | |
| 2014-09-27 | $895.00M 8-K · filed 2014-11-20 | |
| 2014-06-28 | $930.00M 10-KT · filed 2016-02-25 | |
| 2014-03-29 | $965.00M 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $1.00B 10-Q · filed 2014-02-06 | |
| 2013-09-06 | $1.00B 10-K · filed 2018-03-01 | |
| 2013-06-29 | $400.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |